» Articles » PMID: 37922934

A Framework for Standardised Tissue Sampling and Processing During Resection of Diffuse Intracranial Glioma: Joint Recommendations from Four RANO Groups

Abstract

Surgical resection represents the standard of care for people with newly diagnosed diffuse gliomas, and the neuropathological and molecular profile of the resected tissue guides clinical management and forms the basis for research. The Response Assessment in Neuro-Oncology (RANO) consortium is an international, multidisciplinary effort that aims to standardise research practice in neuro-oncology. These recommendations represent a multidisciplinary consensus from the four RANO groups: RANO resect, RANO recurrent glioblastoma, RANO radiotherapy, and RANO/PET for a standardised workflow to achieve a representative tumour evaluation in a disease characterised by intratumoural heterogeneity, including recommendations on which tumour regions should be surgically sampled, how to define those regions on the basis of preoperative imaging, and the optimal sample volume. Practical recommendations for tissue sampling are given for people with low-grade and high-grade gliomas, as well as for people with newly diagnosed and recurrent disease. Sampling of liquid biopsies is also addressed. A standardised workflow for subsequent handling of the resected tissue is proposed to avoid information loss due to decreasing tissue quality or insufficient clinical information. The recommendations offer a framework for prospective biobanking studies.

Citing Articles

Rapid brain tumor classification from sparse epigenomic data.

Brandl B, Steiger M, Kubelt C, Rohrandt C, Zhu Z, Evers M Nat Med. 2025; .

PMID: 40021833 DOI: 10.1038/s41591-024-03435-3.


A Radiologist's Guide to IDH-Wildtype Glioblastoma for Efficient Communication With Clinicians: Part I-Essential Information on Preoperative and Immediate Postoperative Imaging.

Vollmuth P, Karschnia P, Sahm F, Park Y, Ahn S, Jain R Korean J Radiol. 2025; 26(3):246-268.

PMID: 39999966 PMC: 11865903. DOI: 10.3348/kjr.2024.0982.


Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnostics.

Ritter M, Blume C, Tang Y, Patel A, Patel B, Berghaus N Nat Cancer. 2025; 6(2):292-306.

PMID: 39880907 PMC: 11864981. DOI: 10.1038/s43018-024-00904-z.


Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.

Biswas D, Liu Y, Herrero J, Wu Y, Moore D, Karasaki T Nat Cancer. 2025; 6(1):86-101.

PMID: 39789179 PMC: 11779643. DOI: 10.1038/s43018-024-00883-1.


Cancer neuroscience and glioma: clinical implications.

Westphal M, Drexler R, Maire C, Ricklefs F, Lamszus K Acta Neurochir (Wien). 2025; 167(1):2.

PMID: 39752006 PMC: 11698767. DOI: 10.1007/s00701-024-06406-2.


References
1.
Schafer N, Gielen G, Rauschenbach L, Kebir S, Till A, Reinartz R . Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors. J Transl Med. 2019; 17(1):96. PMC: 6425567. DOI: 10.1186/s12967-019-1846-y. View

2.
Barthel F, Johnson K, Varn F, Moskalik A, Tanner G, Kocakavuk E . Longitudinal molecular trajectories of diffuse glioma in adults. Nature. 2019; 576(7785):112-120. PMC: 6897368. DOI: 10.1038/s41586-019-1775-1. View

3.
Kim M, Sun Y, Aryal M, Parmar H, Piert M, Rosen B . A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma. Int J Radiat Oncol Biol Phys. 2021; 110(3):792-803. PMC: 8920120. DOI: 10.1016/j.ijrobp.2021.01.033. View

4.
Prada F, Del Bene M, Fornaro R, Vetrano I, Martegani A, Aiani L . Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. Neurosurg Focus. 2016; 40(3):E7. DOI: 10.3171/2015.11.FOCUS15573. View

5.
Djirackor L, Halldorsson S, Niehusmann P, Leske H, Capper D, Kuschel L . Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy. Neurooncol Adv. 2021; 3(1):vdab149. PMC: 8557693. DOI: 10.1093/noajnl/vdab149. View